Deferred Tax Assets, Valuation Allowance of Regen BioPharma Inc from 31 Mar 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Regen BioPharma Inc quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Mar 2014 to 31 Dec 2025.
  • Regen BioPharma Inc Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $4,758,405.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Regen BioPharma Inc Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $4,758,405 31 Dec 2025 10-Q 13 Feb 2026 2026 Q1
Q3 2025 $4,555,240 +$267,645 +6.2% 30 Sep 2025 10-Q 13 Feb 2026 2026 Q1
Q3 2024 $4,287,595 +$140,334 +3.4% 30 Sep 2024 10-K 30 Dec 2025 2025 FY
Q3 2023 $4,147,261 -$242,866 -5.5% 30 Sep 2023 10-K 13 May 2025 2024 FY
Q3 2022 $4,390,127 -$513,142 -10% 30 Sep 2022 10-K 15 Nov 2022 2022 FY
Q3 2021 $4,903,269 +$1,420,699 +41% 30 Sep 2021 10-K 22 Dec 2021 2021 FY
Q3 2020 $3,482,570 -$717,028 -17% 30 Sep 2020 10-K 04 Aug 2021 2020 FY
Q3 2019 $4,199,598 +$533,619 +15% 30 Sep 2019 10-K 21 Jun 2021 2019 FY
Q4 2018 $3,596,630 -$1,682,547 -32% 31 Dec 2018 10-Q 12 Feb 2019 2019 Q1
Q3 2018 $3,665,979 -$666,247 -15% 30 Sep 2018 10-K 27 Dec 2018 2018 FY
Q2 2018 $3,461,445 -$445,094 -11% 30 Jun 2018 10-Q 06 Aug 2018 2018 Q3
Q1 2018 $3,498,305 +$483,305 +16% 31 Mar 2018 10-Q 14 May 2018 2018 Q2
Q4 2017 $5,279,177 -$2,455,448 -32% 31 Dec 2017 10-Q 06 Feb 2018 2018 Q1
Q3 2017 $4,332,226 -$2,544,042 -37% 30 Sep 2017 10-K 05 Jan 2018 2017 FY
Q2 2017 $3,906,539 -$2,138,205 -35% 30 Jun 2017 10-Q 07 Aug 2017 2017 Q3
Q1 2017 $3,015,000 -$2,228,336 -42% 31 Mar 2017 10-Q 05 May 2017 2017 Q2
Q4 2016 $7,734,625 +$2,862,020 +59% 31 Dec 2016 10-Q/A 28 Apr 2017 2017 Q1
Q3 2016 $6,876,268 +$2,635,202 +62% 30 Sep 2016 10-K/A 28 Apr 2017 2016 FY
Q2 2016 $6,044,744 +$2,007,910 +50% 30 Jun 2016 10-Q/A 28 Apr 2017 2016 Q3
Q1 2016 $5,243,336 +$1,737,708 +50% 31 Mar 2016 10-Q/A 28 Apr 2017 2016 Q2
Q4 2015 $4,872,605 +$5,381,846 31 Dec 2015 10-Q/A 28 Apr 2017 2016 Q1
Q3 2015 $4,241,066 +$4,675,782 30 Sep 2015 10-K/A 28 Apr 2017 2015 FY
Q2 2015 $4,036,834 +$4,405,386 30 Jun 2015 10-Q/A 28 Apr 2017 2015 Q3
Q1 2015 $3,505,628 +$3,817,732 31 Mar 2015 10-Q/A 28 Apr 2017 2015 Q2
Q4 2014 $509,241 31 Dec 2014 10-Q 04 Feb 2015 2015 Q1
Q3 2014 $434,716 30 Sep 2014 10-K 18 Dec 2014 2014 FY
Q2 2014 $368,552 30 Jun 2014 10-Q 07 Aug 2014 2014 Q3
Q1 2014 $312,104 31 Mar 2014 10-Q 05 May 2014 2014 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.